218 related articles for article (PubMed ID: 8722838)
1. Recent advances in the management of cryptococcal meningitis in patients with AIDS.
Powderly WG
Clin Infect Dis; 1996 May; 22 Suppl 2():S119-23. PubMed ID: 8722838
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
4. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
[No Abstract] [Full Text] [Related]
5. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
6. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
7. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Nelson MR; Fisher M; Cartledge J; Rogers T; Gazzard BG
AIDS; 1994 May; 8(5):651-4. PubMed ID: 8060545
[TBL] [Abstract][Full Text] [Related]
8. Therapy for cryptococcal meningitis in patients with AIDS.
Powderly WG
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S54-9. PubMed ID: 1562696
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal meningitis and AIDS.
Powderly WG
Clin Infect Dis; 1993 Nov; 17(5):837-42. PubMed ID: 8286622
[TBL] [Abstract][Full Text] [Related]
11. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
12. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.
Chang LW; Phipps WT; Kennedy GE; Rutherford GW
Cochrane Database Syst Rev; 2005 Jul; (3):CD004773. PubMed ID: 16034947
[TBL] [Abstract][Full Text] [Related]
13. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Graybill JR
Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302
[No Abstract] [Full Text] [Related]
15. Editorial response: management of cryptococcal meningitis--have we answered all the questions?
Powderly WG
Clin Infect Dis; 1996 Feb; 22(2):329-30. PubMed ID: 8838191
[No Abstract] [Full Text] [Related]
16. Initial treatment of cryptococcal meningitis in AIDS.
Chotmongkol V; Arayawichanont A; Sawanyawisuth K; Thavornpitak Y
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):170-3. PubMed ID: 15906662
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
19. Free fluconazole for cryptococcal meningitis: too little of a good thing?
Hamill RJ
Clin Infect Dis; 2006 Oct; 43(8):1074-6. PubMed ID: 16983623
[No Abstract] [Full Text] [Related]
20. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
